The main aim of this study is to test an intervention to reduce unsafe drinking among HIV-positive primary care patients. The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system). Subjects who receive the enhanced motivational interview are expected to show greater improvements in drinking than individuals who receive the standard motivational interview or view a DVD on HIV self-care.

The intervention consists of a brief motivational interview, which is combined with daily alcohol monitoring through the use of an interactive voice response system IVR (automated telephone system).

Active Comparator: 2- standard MI

The intervention consists of a standard motivational interview or viewing a DVD on HIV self-care.

Behavioral: Standard Motivational Interview or viewing DVD

Brief motivational interview, viewing a DVD on HIV self-care.

Detailed Description:

HIV infection is a widespread health problem in the U.S. Antiretroviral treatment has increased longevity and changed the nature of risk factors for morbidity and mortality. Alcohol consumption has become an increasingly serious health issue among HIV primary care patients. Drinking is a key factor in progression to severe liver damage (especially those co-infected with hepatitis), and liver disease is now one of the most common causes of death among those with HIV. Excess drinking is also associated with medication noncompliance, reduces the effect of antiretroviral treatment, and is linked to other health problems. Therefore, helping HIV patients reduce unsafe drinking is crucial to their long-term health. The intervention combines the brief MI, an established, evidence-based counseling approach, with an innovative procedure designed to strengthen the effects of the MI. An effective, easily implemented alcohol-reduction intervention could be incorporated into standard care in HIV clinics helping prevent or slow the progress of some medical problems in HIV-infected individuals, improve medication compliance, prolong lifespan and decrease risk behavior associated with alcohol use.

Participants have had 4 or more drinks on any day in the prior 30 days assessed via standardized questions.

Participants are referred to a study MI counselor by clinic staff as needing an intervention for drinking

Participants agree to random assignment and provide informed consent

Exclusion Criteria:

Participants who are currently psychotic, suicidal or homicidal.

Participants who have definite plans to leave the greater New York metropolitan area within the study period.

Participants who demonstrate gross cognitive impairment as evidenced on the Halstead-Reitain Trails (A).

Participants who do not speak English or Spanish, or have hearing impairments that preclude use of the telephone.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00371969